OHSU's Knight Cancer Institute
The OHSU Knight Cancer Institute is a pioneer in personalized cancer treatment and research, led by Dr. Brian Druker, whose development of Gleevec transformed Chronic Myeloid Leukemia from a fatal disease to a manageable one and proved that targeted therapies can work. The institute focuses on precision oncology, the early detection, prevention, and treatment of cancer, and creating a welcoming and supportive environment for its caregivers, researchers, and support personnel. We work as a connected team in our fight to end cancer as we know it. We’d love for you to join us!
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No